相关实验视频
Updated: Jul 15, 2025

06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
222
在用托法西提尼布治疗的复发性扩散前硬化症的情况下,分支视网膜静脉封闭
Anitha Manoharan1, Harshita Atmakur1, Parthopratim Dutta Majumder1
1Department of Uvea, Sankara Nethralaya, 41, College Road, Nungambakkam, Chennai, 600006, India.
Journal of ophthalmic inflammation and infection
|September 27, 2023
概括
托法西提尼布是一种JAK/STAT抑制剂,改善了风湿性关节炎患者的硬化症. 然而,它与随后的分支视网膜静脉封闭有关,突出显示了血栓栓塞事件的风险.
科学领域:
- 眼科医生 眼科 眼科
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非死性硬化症可能是一个具有挑战性的疾病,通常与类风湿性关节炎等系统性自身免疫性疾病有关.
- 皮质类固醇是一种常见的初始治疗方法,但对于持续的症状可能并不总是足够的.
研究的目的:
- 报告一个用tofacitinib治疗的非死性硬化症病例.
- 为了突出视网膜血管封闭的潜在风险作为与托法西替尼治疗相关的血栓栓塞事件.
主要方法:
- 一名47岁的患有高血压和类风湿性关节炎的妇女接受了托法西替尼治疗耐火性硬化症.
- 对临床反应和 fundus 检查进行了监测.
主要成果:
- 托法西替尼与口服皮质类固醇联合使用,导致硬化症的改善.
- 在随访期间,在左眼中检测到一个上支视网膜静脉封闭.
结论:
- 在患有自身免疫性疾病的患者中,托法西替尼可能对耐火性硬化症有效.
- 临床医生在启动托法西提尼布时,应警发生血栓栓塞事件,包括视网膜血管封闭,特别是在患有并发症的患者中.
相关概念视频
Open Angle Glaucoma: Treatment
474
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
474
Angle Closure Glaucoma: Treatment
555
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
555
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
164
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
164
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
186
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
186
Glaucoma: Overview
614
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
614

